Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF AUGUST 27, 2004 FBO #1005
SOLICITATION NOTICE

R -- Impact of a New process for Formulary Decision Makers

Notice Date
8/25/2004
 
Notice Type
Solicitation Notice
 
NAICS
541618 — Other Management Consulting Services
 
Contracting Office
Department of Health and Human Services, Program Support Center, Division of Acquisition Management, Parklawn Building Room 5-101 5600 Fishers Lane, Rockville, MD, 20857
 
ZIP Code
20857
 
Solicitation Number
04r000210
 
Response Due
9/13/2004
 
Archive Date
9/28/2004
 
Point of Contact
Nora Tyson, Contract Specialist, Phone 301-443-5229, Fax 301-443-3238, - Janet Miller, Contracting Officer, Phone 301-443-2478, Fax 301-443-3849,
 
E-Mail Address
ntyson@psc.gov, jmiller@psc.gov
 
Small Business Set-Aside
Total Small Business
 
Description
The purpose of this contract is to assess the impact of a new process for formulary decision makers to obtain information, including cost-effectiveness information, on drug products that are being considered for inclusion on formularies. The project goal is to facilitate and guide improvements in this process. The project is consistent with the House Appropriation Committee Report encouraging AHRQ to ?support an initiative to identify and make easily accessible the findings of existing, scientifically sound, cost-effectiveness studies of new clinical interventions and technologies.? The contractor will analyze the contents of dossiers submitted by pharmaceutical companies in response to requests by managed care organizations and others as part of their process for reviewing drugs for inclusion on formularies. The focus of the analysis will be an assessment of the quality of dossiers prepared according to the American Academy of Managed Care Pharmacy (AMCP) Format for Formulary Submissions, a guideline developed in 2000. Specifically, the analysis will determine whether the evidence of clinical effectiveness submitted using this Format is complete and appropriate, evaluate the quality and extent of information submitted addressing off-label uses of the drug in question, and evaluate the quality of economic information submitted. With respect to economic information, the contractor shall focus on 1) estimates of effectiveness in cost-effectiveness analysis (CEA), assessing whether the CEA has considered all relevant clinical studies, and the quality of studies used as a basis for these estimates including their use of relevant comparators; 2) use of modeling, assessing such questions as the appropriateness of extrapolation beyond available study endpoints; and 3) other aspects of CEA methods. The contractor shall also collect information about the advantages and problems encountered in implementing a structured format to obtain information from drug companies, including resource demands of the process. All findings will be detailed in a report due at the close of the project. The contractor shall produce the following scheduled reports/deliverables within the time frame indicated. Tasks: 1. Plan detailing sites and dates for information collection and data collection instruments. Should identify data elements that will address requirements outlined in statement of work. Due Date - Sept 31, 2004 2. Progress Report - Due Date - Feb 1, 2005 3. Draft Report - Due Date - July 1, 2005 4. Final Report - Due Date - Sept 30, 2005 The proposed simplified acquisition is for services for which the Government intends to solicit and negotiate with only one source under authority of far 6.302. Interested persons may identify their interest by responding to the requirement within 10 days after the date of publication of this notice. A determination by the government not to compete this proposed simplified acquisition based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. No solicitation is available. For further information, please contact Nora Tyson in Rm. 5C-03, Parklawn Building, 5600 Fishers Lane, Rockville, MD. 20857 or on 301-443-2475.
 
Place of Performance
Address: 718 Huntington Avenue, Boston, MA
Zip Code: 02115
Country: USA
 
Record
SN00653572-W 20040827/040826074640 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.